Review: Beta blockers are less effective than other antihypertensive drugs for reducing risk of stroke in primary hypertension

Affiliations

Comment

Peter Rudd. Evid Based Med. 2006 Jun.

. 2006 Jun;11(3):85.

doi: 10.1136/ebm.11.3.85.

No abstract available

Comment on

Should beta blockers remain first choice in the treatment of primary hypertension? A meta-analysis.
Lindholm LH, Carlberg B, Samuelsson O. Lindholm LH, et al. Lancet. 2005 Oct 29-Nov 4;366(9496):1545-53. doi: 10.1016/S0140-6736(05)67573-3. Lancet. 2005. PMID: 16257341 Review.

Review: beta-blockers are less effective than other antihypertensive drugs for reducing risk for stroke in primary hypertension.
Rudd P. Rudd P. ACP J Club. 2006 May-Jun;144(3):67. ACP J Club. 2006. PMID: 16646611 No abstract available.
Beta-adrenergic antagonists in hypertension: a review of the evidence.
Warmack TS, Estes MA, Heldenbrand S, Franks AM. Warmack TS, et al. Ann Pharmacother. 2009 Dec;43(12):2031-43. doi: 10.1345/aph.1M381. Ann Pharmacother. 2009. PMID: 19934392 Review.
A meta-analysis of 94,492 patients with hypertension treated with beta blockers to determine the risk of new-onset diabetes mellitus.
Bangalore S, Parkar S, Grossman E, Messerli FH. Bangalore S, et al. Am J Cardiol. 2007 Oct 15;100(8):1254-62. doi: 10.1016/j.amjcard.2007.05.057. Epub 2007 Aug 10. Am J Cardiol. 2007. PMID: 17920367
[Antihypertensive drugs in diabetic's hypertension].
Pugliese F. Pugliese F. G Ital Nefrol. 2006 Jan-Feb;23 Suppl 34:S26-31. G Ital Nefrol. 2006. PMID: 16633991 Review. Italian.
Smoking, antihypertensive treatment benefit, and comprehensive antihypertensive treatment approach: some thoughts on the results of the International Prospective Primary Prevention Study in Hypertension.
Bolli P, Bühler FR, McKenzie JK. Bolli P, et al. J Cardiovasc Pharmacol. 1990;16 Suppl 7:S77-80. J Cardiovasc Pharmacol. 1990. PMID: 1708033